8 บริษัท จี สตีล จ ำกัด (มหำชน) G Steel Public Company Limited Management Discussion and Analysis Quarter 1 Ending 31 March 2020 G Steel Public Company Limited Page 1/7 Management Discussion and
MDA_Eng_3Q22 final.pdf Management Discussion and Analysis for the 3rd Quarter 2022 Ended November 30, 2022 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted
and promotional spending as a percentage to sales. In addition, administrative expenses declined by -44.9% YoY in Q4’18 due to last year’s various extra expenses aforementioned. The Company Q4’18
Page 1 from 5 Management Discussion and Analysis Performance for Quarter 3/2020 WICE Logistics Public Company Limited Performance Unit : million baht Statement of financial position Q3/2020 Q3/2019
2019 in amount of 87.42 million baht, as subsidiary, Grace Water Med Company Limited (“GWM”), operating business of producing and selling dialysis solutions and various medical supplies, which increased
37% EBITDA 81 111 36% 223 288 29% Net Profit (Loss) for the Company 34 54 59% 82 131 60% Gross Profit Margin (%) 64.6% 66.0% 1.3% 63.2% 64.8% 1.6% EBITDA Margin1 (%) 32.8% 32.6% (0.2%) 32.6% 31.6% (1.0
····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ···...
, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
426 76% EBITDA 24 81 238% 114 223 96% Net Profit (Loss) for the Company (13) 34 362% (9) 82 1,011% Gross Profit Margin (%) 52.2% 64.6% 12.5% 56.1% 63.2% 7.1% EBITDA Margin1 (%) 20.7% 32.8% 12.1% 26.2